Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.

Hongge LiangXia SongYuhui ZhangShucai ZhangFang LiJian FangJunling LiLi LiangLigong NieKewei MaLiangming ZhangXiaohong WangJunjun XuYanxia WeiJinghui WangQi SongGuangming TianYuxin MuYangchun GuLei YangPing SunWei ZhongJing ZhaoYan XuMinjiang ChenMengzhao Wang

Published in: Thoracic cancer (2019)

Squamous NSCLC patients should also be routinely tested to determine their EGFR/ALK statuses. The first-line targeted therapy rate remains low in Chinese patients with NSCLC.

Keyphrases

advanced non small cell lung cancer
newly diagnosed
small cell lung cancer
epidermal growth factor receptor
end stage renal disease
ejection fraction
peritoneal dialysis
tyrosine kinase
prognostic factors
gene expression
patient reported outcomes
artificial intelligence
low grade